Ligand Pharmaceuticals LGND Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's net income?
- Ligand Pharmaceuticals (LGND) reported net income of -$13.35M in Q1 2026.
- How has Ligand Pharmaceuticals's net income changed year-over-year?
- Ligand Pharmaceuticals's net income increased by 68.6% year-over-year, from -$42.45M to -$13.35M.
- What is the long-term trend for Ligand Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Ligand Pharmaceuticals's net income has grown at a 21.5% compound annual growth rate (CAGR), from $57.14M to $124.45M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.